{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:58:53Z","timestamp":1785214733994,"version":"3.55.0"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Travel has been increasing globally since the COVID-19 pandemic ended, including travel from the Gulf Cooperation Council (GCC) countries to international destinations. This creates unique risks for travelers, who may return with various infectious diseases. Travel medicine is a well-established medical specialty worldwide; however, it has only recently been introduced within the GCC, with limited healthcare and public awareness of the importance of these services in preventing infectious diseases among international travelers. This document presents travel medicine recommendations for practicing clinicians in the GCC to help prevent these diseases through pre-travel consultation.<\/jats:p>","DOI":"10.4103\/sjmms.sjmms_998_25","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:00:08Z","timestamp":1784664008000},"page":"183-196","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pre-Travel Consultation for the Prevention of Infectious Diseases among International Travelers from GCC Countries: Travel Medicine Recommendations for Clinicians"],"prefix":"10.4103","volume":"14","author":[{"given":"Mazin","family":"Barry","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Infectious Diseases Unit, College of Medicine, King Saud University, Riyadh, Saudi Arabia"},{"name":"Division of Infectious Diseases, Faculty of Medicine, University of Ottawa, Ottawa, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaffar A.","family":"Al-Tawfiq","sequence":"additional","affiliation":[{"name":"Specialty Internal Medicine and Quality Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia"},{"name":"Department of Medicine, Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, IN, USA"},{"name":"Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayssal","family":"Farahat","sequence":"additional","affiliation":[{"name":"Infection Prevention and Control Program, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia"},{"name":"King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alzunitan","sequence":"additional","affiliation":[{"name":"Infection Prevention and Control Program, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia"},{"name":"King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Almaziad","sequence":"additional","affiliation":[{"name":"Infection Prevention and Control Program, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Alshamrani","sequence":"additional","affiliation":[{"name":"Infection Prevention and Control Program, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia"},{"name":"King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Memish","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"},{"name":"King Salman Humanitarian Aid and Relief Center, Riyadh, Saudi Arabia"},{"name":"Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"R4-20260728","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-158-6-201303190-00005","article-title":"GeoSentinel surveillance of illness in returned travelers, 2007-2011","volume":"158","author":"Leder","year":"2013","journal-title":"Ann Intern Med"},{"key":"R5-20260728","doi-asserted-by":"crossref","first-page":"taad003","DOI":"10.1093\/jtm\/taad003","article-title":"Infections in travellers returning to the UK: A retrospective analysis (2015-2020)","volume":"30","author":"Warner","year":"2023","journal-title":"J Travel Med"},{"key":"R6-20260728","doi-asserted-by":"crossref","first-page":"e083065","DOI":"10.1136\/bmjopen-2023-083065","article-title":"ITIT Global Network. Surveillance of global, travel-related illness using a novel app: A multivariable, cross-sectional study","volume":"14","author":"Lovey","year":"2024","journal-title":"BMJ Open"},{"key":"R8-20260728","doi-asserted-by":"crossref","first-page":"taad145","DOI":"10.1093\/jtm\/taad145","article-title":"Travel and tourism to the Kingdom of Saudi Arabia: What are the health risks?","volume":"31","author":"Memish","year":"2024","journal-title":"J Travel Med"},{"key":"R9-20260728","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s44197-025-00394-x","article-title":"The need for a travel medicine diploma in Saudi Arabia: Addressing national and global health priorities","volume":"15","author":"Sheerah","year":"2025","journal-title":"J Epidemiol Glob Health"},{"key":"R10-20260728","doi-asserted-by":"crossref","first-page":"102432","DOI":"10.1016\/j.tmaid.2022.102432","article-title":"Not every skin rash in a returning adult male traveler is monkeypox","volume":"50","author":"Barry","year":"2022","journal-title":"Travel Med Infect Dis"},{"key":"R11-20260728","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/M16-1565","article-title":"A reporting tool for practice guidelines in health care: The RIGHT statement","volume":"166","author":"Chen","year":"2017","journal-title":"Ann Intern Med"},{"key":"R12-20260728","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/s12072-021-10232-4","article-title":"The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention","volume":"15","author":"Cao","year":"2021","journal-title":"Hepatol Int"},{"issue":"Suppl 1","key":"R13-20260728","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0264-410X(99)00470-3","article-title":"Clinical course and consequences of hepatitis A infection","volume":"18","author":"Ciocca","year":"2000","journal-title":"Vaccine"},{"key":"R14-20260728","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/pathogens14050454","article-title":"Hepatitis A and E viruses are important agents of acute severe hepatitis in Asia: A narrative review","volume":"14","author":"Sasaki-Tanaka","year":"2025","journal-title":"Pathogens"},{"key":"R15-20260728","doi-asserted-by":"crossref","first-page":"taae125","DOI":"10.1093\/jtm\/taae125","article-title":"Hepatitis a vaccine immunogenicity and boostability in adults receiving immunosuppressive therapy and adults living with HIV: A prospective single-centre cohort study","volume":"32","author":"Schnyder","year":"2025","journal-title":"J Travel Med"},{"key":"R16-20260728","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40121-025-01278-0","article-title":"Long-term antibody persistence after hepatitis a vaccination in healthy toddlers: Insights from modeling","volume":"15","author":"Espul","year":"2026","journal-title":"Infect Dis Ther"},{"key":"R17-20260728","doi-asserted-by":"crossref","first-page":"taab012","DOI":"10.1093\/jtm\/taab012","article-title":"Typhoid and paratyphoid fever: A clinical seminar","volume":"28","author":"Manesh","year":"2021","journal-title":"J Travel Med"},{"key":"R18-20260728","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2471\/BLT.06.039818","article-title":"A study of typhoid fever in five Asian countries: Disease burden and implications for controls","volume":"86","author":"Ochiai","year":"2008","journal-title":"Bull World Health Organ"},{"key":"R19-20260728","doi-asserted-by":"crossref","first-page":"618","DOI":"10.15585\/mmwr.mm6920a2","article-title":"Update on extensively drug-resistant Salmonella serotype typhi infections among travelers to or from Pakistan and report of ceftriaxone-resistant Salmonella serotype typhi infections among travelers to Iraq \u2013 United States, 2018-2019","volume":"69","author":"Fran\u00e7ois Watkins","year":"2020","journal-title":"Morb Mortal Wkly Rep"},{"key":"R20-20260728","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.cgh.2009.11.015","article-title":"Traveling internationally: Avoiding and treating travelers' diarrhea","volume":"8","author":"Dupont","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R21-20260728","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1111\/j.1708-8305.2001.tb00543.x","article-title":"Epidemiology of travelers' diarrhea","volume":"8","author":"Castelli","year":"2001","journal-title":"J Travel Med"},{"key":"R22-20260728","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1715163519853308","article-title":"Travelers' diarrhea: Clinical practice guidelines for pharmacists","volume":"152","author":"Fernandes","year":"2019","journal-title":"Can Pharm J (Ott)"},{"key":"R23-20260728","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/jtm\/tax040","article-title":"Use of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant Enterobacteriaceae: Setting the stage for consensus recommendations","volume":"24","author":"DuPont","year":"2017","journal-title":"J Travel Med"},{"key":"R24-20260728","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jama.1987.03390100085031","article-title":"Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate","volume":"257","author":"DuPont","year":"1987","journal-title":"JAMA"},{"key":"R25-20260728","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1708-8305.2009.00385.x","article-title":"Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico","volume":"17","author":"Martinez-Sandoval","year":"2010","journal-title":"J Travel Med"},{"key":"R26-20260728","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/AAC.45.2.643-644.2001","article-title":"In vitro activity of rifaximin against enteropathogens producing traveler's diarrhea","volume":"45","author":"Sierra","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-20260728","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-142-10-200505170-00005","article-title":"A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea","volume":"142","author":"DuPont","year":"2005","journal-title":"Ann Intern Med"},{"key":"R29-20260728","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/jtm\/tax060","article-title":"Guidelines for the prevention and treatment of travelers' diarrhea: A graded expert panel report","volume":"24","author":"Riddle","year":"2017","journal-title":"J Travel Med"},{"key":"R30-20260728","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/510589","article-title":"Traveler's diarrhea in Thailand: Randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen","volume":"44","author":"Tribble","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R31-20260728","doi-asserted-by":"crossref","first-page":"ofy161","DOI":"10.1093\/ofid\/ofy161","article-title":"A review of the global burden, new diagnostics, and current therapeutics for amebiasis","volume":"5","author":"Shirley","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"R32-20260728","doi-asserted-by":"crossref","first-page":"101077","DOI":"10.1016\/j.nmni.2022.101077","article-title":"The cholera challenge: How should the world respond?","volume":"51","author":"Al-Tawfiq","year":"2022","journal-title":"New Microbes New Infect"},{"key":"R33-20260728","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(22)00330-0","article-title":"Cholera","volume":"399","author":"Kanungo","year":"2022","journal-title":"Lancet"},{"key":"R34-20260728","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMc2004773","article-title":"Highly resistant cholera outbreak strain in Zimbabwe","volume":"383","author":"Mashe","year":"2020","journal-title":"N Engl J Med"},{"key":"R35-20260728","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/s41564-023-01472-1","article-title":"Genomic epidemiology reveals multidrug resistant plasmid spread between Vibrio cholerae lineages in Yemen","volume":"8","author":"Lassalle","year":"2023","journal-title":"Nat Microbiol"},{"key":"R36-20260728","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1038\/s41467-024-51428-0","article-title":"An unusual two-strain cholera outbreak in Lebanon, 2022-2023: A genomic epidemiology study","volume":"15","author":"Abou Fayad","year":"2024","journal-title":"Nat Commun"},{"key":"R37-20260728","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMc2408761","article-title":"Long-distance spread of a highly drug-resistant epidemic cholera strain","volume":"391","author":"Rouard","year":"2024","journal-title":"N Engl J Med"},{"key":"R38-20260728","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"N Engl J Med"},{"key":"R39-20260728","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0264-410X(95)00122-H","article-title":"Field trial of inactivated oral cholera vaccines in Bangladesh: Results from 5 years of follow-up","volume":"14","author":"van Loon","year":"1996","journal-title":"Vaccine"},{"key":"R40-20260728","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/1060028017698162","article-title":"Vaxchora: A single-dose oral cholera vaccine","volume":"51","author":"Cabrera","year":"2017","journal-title":"Ann Pharmacother"},{"issue":"Suppl 1","key":"R41-20260728","doi-asserted-by":"crossref","first-page":"A127","DOI":"10.1016\/j.vaccine.2019.06.082","article-title":"Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: Lessons learned and way forward","volume":"38","author":"Islam","year":"2020","journal-title":"Vaccine"},{"key":"R42-20260728","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2018.09.026","article-title":"The Euvichol story \u2013 Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships","volume":"36","author":"Odevall","year":"2018","journal-title":"Vaccine"},{"key":"R43-20260728","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/jama.2016.10042","volume":"316","year":"2016","journal-title":"JAMA"},{"key":"R45-20260728","doi-asserted-by":"crossref","first-page":"e00104","DOI":"10.1128\/CMR.00104-19","article-title":"Imported malaria in countries where malaria is not endemic: A comparison of semi-immune and nonimmune travelers","volume":"33","author":"Mischlinger","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"R46-20260728","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2022.12366","article-title":"Diagnosis, treatment, and prevention of malaria in the US: A review","volume":"328","author":"Daily","year":"2022","journal-title":"JAMA"},{"key":"R47-20260728","doi-asserted-by":"crossref","first-page":"e0112121","DOI":"10.1128\/AAC.01121-21","article-title":"Evolution of multidrug resistance in Plasmodium falciparum: A longitudinal study of genetic resistance markers in the greater Mekong subregion","volume":"65","author":"Imwong","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"R48-20260728","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1016\/S1473-3099(23)00126-3","article-title":"RTS, S\/AS01 malaria vaccine-proven safe and effective?","volume":"23","author":"Bj\u00f6rkman","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"R49-20260728","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","article-title":"Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in African children: A multicentre, double-blind, randomised, phase 3 trial","volume":"403","author":"Datoo","year":"2024","journal-title":"Lancet"},{"key":"R50-20260728","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S1473-3099(22)00442-X","article-title":"Efficacy and immunogenicity of R21\/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: A phase 1\/2b randomised controlled trial","volume":"22","author":"Datoo","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"R52-20260728","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMra041927","article-title":"Dengue in travelers","volume":"353","author":"Wilder-Smith","year":"2005","journal-title":"N Engl J Med"},{"key":"R53-20260728","doi-asserted-by":"crossref","first-page":"940","DOI":"10.7326\/M23-0721","article-title":"Clinical characteristics and outcomes among travelers with severe dengue: A GeoSentinel analysis","volume":"176","author":"Huits","year":"2023","journal-title":"Ann Intern Med"},{"key":"R54-20260728","doi-asserted-by":"crossref","first-page":"taad085","DOI":"10.1093\/jtm\/taad085","article-title":"Travel vaccines-priorities determined by incidence and impact","volume":"30","author":"Steffen","year":"2023","journal-title":"J Travel Med"},{"key":"R55-20260728","doi-asserted-by":"crossref","first-page":"taad146","DOI":"10.1093\/jtm\/taad146","article-title":"Dengue severity in travellers: Challenges and insights","volume":"30","author":"McGuinness","year":"2023","journal-title":"J Travel Med"},{"key":"R56-20260728","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1080\/14787210.2021.1949983","article-title":"Dengue vaccine: An update","volume":"19","author":"Huang","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R57-20260728","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/cid\/ciab864","article-title":"Three-year efficacy and safety of Takeda's dengue vaccine candidate (TAK-003)","volume":"75","author":"Rivera","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R58-20260728","doi-asserted-by":"crossref","first-page":"102598","DOI":"10.1016\/j.tmaid.2023.102598","article-title":"Qdenga\u00ae -a promising dengue fever vaccine; can it be recommended to non-immune travelers?","volume":"54","author":"Angelin","year":"2023","journal-title":"Travel Med Infect Dis"},{"key":"R59-20260728","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"key":"R60-20260728","doi-asserted-by":"crossref","first-page":"11632","DOI":"10.3390\/ijms231911632","article-title":"Tick-borne encephalitis virus RNA found in frozen goat's milk in a family outbreak","volume":"23","author":"Mylonaki","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R61-20260728","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/QCO.0000000000000924","article-title":"Tick-borne encephalitis","volume":"36","author":"Johnson","year":"2023","journal-title":"Curr Opin Infect Dis"},{"key":"R62-20260728","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.tmaid.2018.11.010","article-title":"Ticks and tick-borne encephalitis in Europe: Challenges for travel medicine","volume":"26","author":"Haditsch","year":"2018","journal-title":"Travel Med Infect Dis"},{"key":"R63-20260728","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1080\/21645515.2016.1218098","article-title":"Tick-borne encephalitis: What travelers should know when visiting an endemic country","volume":"12","author":"Chrdle","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"R64-20260728","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(16)30116-7","article-title":"Yellow fever: A global reckoning","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"R65-20260728","doi-asserted-by":"crossref","first-page":"taaa156","DOI":"10.1093\/jtm\/taaa156","article-title":"What is the reproductive number of yellow fever?","volume":"27","author":"Liu","year":"2020","journal-title":"J Travel Med"},{"key":"R66-20260728","doi-asserted-by":"crossref","first-page":"taad059","DOI":"10.1093\/jtm\/taad059","article-title":"Co-circulation of Murray valley encephalitis virus and Japanese encephalitis virus in South-Eastern Australia","volume":"30","author":"McGuinness","year":"2023","journal-title":"J Travel Med"},{"key":"R67-20260728","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4161\/hv.26902","article-title":"Japanese encephalitis: The virus and vaccines","volume":"10","author":"Yun","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"R68-20260728","first-page":"49","article-title":"Japanese encephalitis vaccine","volume":"103","author":"Mileno","year":"2020","journal-title":"R I Med J (2013)"},{"key":"R69-20260728","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.vaccine.2012.02.005","article-title":"Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine","volume":"30","author":"Desai","year":"2012","journal-title":"Vaccine"},{"key":"R70-20260728","doi-asserted-by":"crossref","first-page":"vex 010","DOI":"10.1093\/ve\/vex010","article-title":"Understanding the evolution and spread of chikungunya virus in the Americas using complete genome sequences","volume":"3","author":"Sahadeo","year":"2017","journal-title":"Virus Evol"},{"key":"R71-20260728","doi-asserted-by":"crossref","first-page":"102543","DOI":"10.1016\/j.tmaid.2023.102543","article-title":"Chikungunya in returning travellers from Bali \u2013 A GeoSentinel case series","volume":"52","author":"Mayer","year":"2023","journal-title":"Travel Med Infect Dis"},{"key":"R72-20260728","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijid.2017.03.006","article-title":"Global expansion of chikungunya virus: Mapping the 64-year history","volume":"58","author":"Wahid","year":"2017","journal-title":"Int J Infect Dis"},{"key":"R73-20260728","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(23)00641-4","article-title":"Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: A double-blind, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"401","author":"Schneider","year":"2023","journal-title":"Lancet"},{"key":"R74-20260728","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(25)00345-9","article-title":"Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: A phase 3, randomised, double-blind, placebo-controlled trial","volume":"405","author":"Richardson","year":"2025","journal-title":"Lancet"},{"key":"R77-20260728","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the global burden of disease study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"R78-20260728","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/S1473-3099(22)00641-7","article-title":"Human rabies despite post-exposure prophylaxis: A systematic review of fatal breakthrough infections after zoonotic exposures","volume":"23","author":"Whitehouse","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"R79-20260728","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.52225\/narra.v2i3.97","article-title":"The outbreak of Ebola virus disease in 2022: A spotlight on a re-emerging global health menace","volume":"2","author":"Al-Tammemi","year":"2022","journal-title":"Narra J"},{"key":"R80-20260728","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tmaid.2014.10.008","article-title":"Ebola and travel-management of imported cases","volume":"12","author":"Brouqui","year":"2014","journal-title":"Travel Med Infect Dis"},{"key":"R81-20260728","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: Final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"R82-20260728","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa1904387","article-title":"Ebola Outbreak response in the DRC with rVSV-ZEBOV-GP ring vaccination","volume":"391","author":"Muyembe","year":"2024","journal-title":"N Engl J Med"},{"key":"R83-20260728","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1473-3099(20)30476-X","article-title":"Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): A randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial","volume":"21","author":"Pollard","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"R84-20260728","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7001a1","article-title":"Use of Ebola vaccine: Recommendations of the advisory committee on immunization practices, United States, 2020","volume":"70","author":"Choi","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"R85-20260728","doi-asserted-by":"crossref","first-page":"102784","DOI":"10.1016\/j.tmaid.2024.102784","article-title":"Vaccinations for Hajj: Enhancing health and global health security","volume":"63","author":"Khan","year":"2025","journal-title":"Travel Med Infect Dis"},{"key":"R86-20260728","doi-asserted-by":"crossref","first-page":"102547","DOI":"10.1016\/j.jiph.2024.102547","article-title":"Hajj vaccination strategies: Preparedness for risk mitigation","volume":"17","author":"Alshamrani","year":"2024","journal-title":"J Infect Public Health"},{"key":"R87-20260728","doi-asserted-by":"crossref","first-page":"107092","DOI":"10.1016\/j.ijid.2024.107092","article-title":"Emergence of invasive meningococcal disease during Hajj pilgrimage \u2013 Vigilance and preparedness, in the post-pandemic year","volume":"145","author":"Al-Tawfiq","year":"2024","journal-title":"Int J Infect Dis"},{"key":"R88-20260728","first-page":"147","article-title":"The Hajj 2019 vaccine requirements and possible new challenges","volume":"9","author":"Al-Tawfiq","year":"2019","journal-title":"J Epidemiol Glob Health"}],"container-title":["Saudi Journal of Medicine &amp; Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/sjmms.sjmms_998_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:01:57Z","timestamp":1785211317000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.4103\/sjmms.sjmms_998_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/sjmms.sjmms_998_25","relation":{},"ISSN":["1658-631X"],"issn-type":[{"value":"1658-631X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2025-11-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}